OTL-104

N/A

Report date: 2024/12/18 17:48:45

Base Information

Drug NameOTL-104
Drug Alias NameOTL-104
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionStem cell replacementsNucleotide-binding oligomerization domain-containing protein 2 gene transference
TargetsNucleotide-binding oligomerization domain-containing protein 2
Therapy Area/IndicationsCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrchard Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesOrchard Therapeutics Plc
Inactive CompaniesN/A
Active IndicationsCrohn Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A